These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 30166697)

  • 21. [Morphologic changes of fallopian tubal epithelium in ovarian serous tumors].
    Wen J; Shi JL; Shen DH; Chen YX; Song QJ
    Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):433-7. PubMed ID: 22932451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Study of High-Grade Serous Ovarian Cancer Origins Implicates the SOX18 Transcription Factor in Tumor Development.
    Lawrenson K; Fonseca MAS; Liu AY; Segato Dezem F; Lee JM; Lin X; Corona RI; Abbasi F; Vavra KC; Dinh HQ; Gill NK; Seo JH; Coetzee S; Lin YG; Pejovic T; Mhawech-Fauceglia P; Rowat AC; Drapkin R; Karlan BY; Hazelett DJ; Freedman ML; Gayther SA; Noushmehr H
    Cell Rep; 2019 Dec; 29(11):3726-3735.e4. PubMed ID: 31825847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Murine Oviductal High-Grade Serous Carcinomas Mirror the Genomic Alterations, Gene Expression Profiles, and Immune Microenvironment of Their Human Counterparts.
    McCool KW; Freeman ZT; Zhai Y; Wu R; Hu K; Liu CJ; Tomlins SA; Fearon ER; Magnuson B; Kuick R; Cho KR
    Cancer Res; 2020 Feb; 80(4):877-889. PubMed ID: 31806642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-neoplastic Fallopian Tube Epithelium Carrying Gene Mutations of a Novel SOX2 Repressor Region is Soil of High-grade Serous Ovarian Cancer.
    Hirohashi Y; Torigoe T
    EBioMedicine; 2016 Aug; 10():17-8. PubMed ID: 27423191
    [No Abstract]   [Full Text] [Related]  

  • 25. Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma.
    de Cristofaro T; Di Palma T; Soriano AA; Monticelli A; Affinito O; Cocozza S; Zannini M
    Oncotarget; 2016 Jul; 7(27):41929-41947. PubMed ID: 27259239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumorigenesis and peritoneal colonization from fallopian tube epithelium.
    Eddie SL; Quartuccio SM; Ó hAinmhir E; Moyle-Heyrman G; Lantvit DD; Wei JJ; Vanderhyden BC; Burdette JE
    Oncotarget; 2015 Aug; 6(24):20500-12. PubMed ID: 25971410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New insights into the pathogenesis of serous ovarian cancer and its clinical impact.
    Levanon K; Crum C; Drapkin R
    J Clin Oncol; 2008 Nov; 26(32):5284-93. PubMed ID: 18854563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer.
    Crum CP; Drapkin R; Kindelberger D; Medeiros F; Miron A; Lee Y
    Clin Med Res; 2007 Mar; 5(1):35-44. PubMed ID: 17456833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Huwe1 Sustains Normal Ovarian Epithelial Cell Transformation and Tumor Growth through the Histone H1.3-
    Yang D; Sun B; Zhang X; Cheng D; Yu X; Yan L; Li L; An S; Jiang H; Lasorella A; Iavarone A; Zhang S; Zou F; Zhao X
    Cancer Res; 2017 Sep; 77(18):4773-4784. PubMed ID: 28687618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 17β-Estradiol sensitizes ovarian surface epithelium to transformation by suppressing Disabled-2 expression.
    Vuong NH; Salah Salah O; Vanderhyden BC
    Sci Rep; 2017 Dec; 7(1):16702. PubMed ID: 29196616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-grade serous ovarian cancer arises from fallopian tube in a mouse model.
    Kim J; Coffey DM; Creighton CJ; Yu Z; Hawkins SM; Matzuk MM
    Proc Natl Acad Sci U S A; 2012 Mar; 109(10):3921-6. PubMed ID: 22331912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of growth hormone secretagogue receptor type 1a, the functional ghrelin receptor, in human ovarian surface epithelium, mullerian duct derivatives, and ovarian tumors.
    Gaytan F; Morales C; Barreiro ML; Jeffery P; Chopin LK; Herington AC; Casanueva FF; Aguilar E; Dieguez C; Tena-Sempere M
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1798-804. PubMed ID: 15585554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conditional inactivation of p53 in mouse ovarian surface epithelium does not alter MIS driven Smad2-dominant negative epithelium-lined inclusion cysts or teratomas.
    Quartuccio SM; Lantvit DD; Bosland MC; Burdette JE
    PLoS One; 2013; 8(5):e65067. PubMed ID: 23741457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ovarian cancer: insights into genetics and pathogeny.
    Liliac L; Amalinei C; Balan R; Grigoras A; Caruntu ID
    Histol Histopathol; 2012 Jun; 27(6):707-19. PubMed ID: 22473692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early transformative changes in normal ovarian surface epithelium induced by oxidative stress require Akt upregulation, DNA damage and epithelial-stromal interaction.
    King SM; Quartuccio SM; Vanderhyden BC; Burdette JE
    Carcinogenesis; 2013 May; 34(5):1125-33. PubMed ID: 23299406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrated Analysis Reveals Tubal- and Ovarian-Originated Serous Ovarian Cancer and Predicts Differential Therapeutic Responses.
    Hao D; Li J; Jia S; Meng Y; Zhang C; Wang L; Di LJ
    Clin Cancer Res; 2017 Dec; 23(23):7400-7411. PubMed ID: 28939742
    [No Abstract]   [Full Text] [Related]  

  • 37. Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.
    Marquez RT; Baggerly KA; Patterson AP; Liu J; Broaddus R; Frumovitz M; Atkinson EN; Smith DI; Hartmann L; Fishman D; Berchuck A; Whitaker R; Gershenson DM; Mills GB; Bast RC; Lu KH
    Clin Cancer Res; 2005 Sep; 11(17):6116-26. PubMed ID: 16144910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cadherin-6 type 2, K-cadherin (CDH6) is regulated by mutant p53 in the fallopian tube but is not expressed in the ovarian surface.
    Karthikeyan S; Lantvit DD; Chae DH; Burdette JE
    Oncotarget; 2016 Oct; 7(43):69871-69882. PubMed ID: 27563818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The fallopian tube as the origin of high grade serous ovarian cancer: review of a paradigm shift.
    Reade CJ; McVey RM; Tone AA; Finlayson SJ; McAlpine JN; Fung-Kee-Fung M; Ferguson SE
    J Obstet Gynaecol Can; 2014 Feb; 36(2):133-140. PubMed ID: 24518912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube.
    Yang J; Zhou Y; Ng SK; Huang KC; Ni X; Choi PW; Hasselblatt K; Muto MG; Welch WR; Berkowitz RS; Ng SW
    BMC Cancer; 2017 Jun; 17(1):422. PubMed ID: 28623900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.